MNOV Medicinova Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MNOV

Price (delayed)

$1.34

Market cap

$65.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.17

Enterprise value

$14.94M

MediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. ...

Highlights
MNOV's EPS is up by 41% year-on-year and by 11% since the previous quarter
MNOV's net income is up by 39% YoY and by 10% from the previous quarter
The debt has grown by 37% YoY and by 5% from the previous quarter
The quick ratio has contracted by 17% from the previous quarter and by 15% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.medicinova.com
Peers: LLY ALKS TEVA NVS

Key stats

What are the main financial stats of MNOV
Market
Shares outstanding
49.05M
Market cap
$65.72M
Enterprise value
$14.94M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.05
Price to sales (P/S)
65.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.94
Earnings
Revenue
$1M
EBIT
-$8.57M
EBITDA
-$8.35M
Free cash flow
-$7.45M
Per share
EPS
-$0.17
Free cash flow per share
-$0.15
Book value per share
$1.27
Revenue per share
$0.02
TBVPS
$1.16
Balance sheet
Total assets
$66.27M
Total liabilities
$3.89M
Debt
$215,926
Equity
$62.38M
Working capital
$47.9M
Liquidity
Debt to equity
0
Current ratio
15.61
Quick ratio
15.55
Net debt/EBITDA
6.08
Margins
EBITDA margin
-835.4%
Gross margin
100%
Net margin
-857.2%
Operating margin
-990%
Efficiency
Return on assets
-12.5%
Return on equity
-13.2%
Return on invested capital
-238.6%
Return on capital employed
-13.6%
Return on sales
-856.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNOV stock price

How has the Medicinova stock price performed over time
Intraday
-3.6%
1 week
-11.84%
1 month
-3.6%
1 year
-38.81%
YTD
-10.67%
QTD
-7.59%

Financial performance

How have Medicinova's revenue and profit performed over time
Revenue
$1M
Gross profit
$1M
Operating income
-$9.9M
Net income
-$8.57M
Gross margin
100%
Net margin
-857.2%
MNOV's net income is up by 39% YoY and by 10% from the previous quarter
The operating income is up by 32% year-on-year and by 11% since the previous quarter
MNOV's operating margin is up by 11% QoQ
The net margin has grown by 10% from the previous quarter

Growth

What is Medicinova's growth rate over time

Valuation

What is Medicinova stock price valuation
P/E
N/A
P/B
1.05
P/S
65.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.94
MNOV's EPS is up by 41% year-on-year and by 11% since the previous quarter
The P/B is 58% lower than the 5-year quarterly average of 2.5 and 30% lower than the last 4 quarters average of 1.5
The equity has declined by 11% year-on-year and by 3.5% since the previous quarter

Efficiency

How efficient is Medicinova business performance
MNOV's ROIC has shrunk by 162% YoY
The ROA rose by 29% YoY and by 7% QoQ
Medicinova's return on equity has increased by 29% YoY and by 7% QoQ
MNOV's return on sales is up by 10% since the previous quarter

Dividends

What is MNOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNOV.

Financial health

How did Medicinova financials performed over time
MNOV's current ratio is down by 17% since the previous quarter and by 16% year-on-year
The quick ratio has contracted by 17% from the previous quarter and by 15% YoY
The debt is 100% less than the equity
The debt has grown by 37% YoY and by 5% from the previous quarter
The equity has declined by 11% year-on-year and by 3.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.